Literature DB >> 11750952

Apoptosis in the first trimester human placenta: the role in maintaining immune privilege at the maternal-foetal interface and in the trophoblast remodelling.

Malgorzata Jerzak1, Paul Bischof.   

Abstract

Apoptosis has been proposed as a mechanism for maintaining immune privilege. Expression of Fas ligand (FasL) by the human trophoblast has been recently accepted as a mechanism providing protection against the lytic action of activated decidual immune cells expressing Fas receptor (FasR). Therefore, the purpose of this review was to determine the role of apoptosis in early pregnancy maintenance according to the latest literature. We used Medline literature search. The data suggest that apoptosis may serve as a previously unsuspected mechanism that induces tolerance of the foetal allograft against maternal immune system. Apoptosis of activated maternal immune cells occurs in the human decidua mainly through Fas-FasL or receptor for TNF-related apoptosis-inducing ligand (TRAIL-R)-TNF-related apoptosis-inducing ligand (TRAIL) signalling. This might be a defence mechanism against rejection of the foetal allograft by the maternal immune system. In addition, in this review contribution of programmed cell death to placental cell turnover and remodelling during first trimester of pregnancy is also discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11750952     DOI: 10.1016/s0301-2115(01)00431-6

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  15 in total

1.  Increased apoptosis in first trimester extravillous trophoblasts from pregnancies at higher risk of developing preeclampsia.

Authors:  Guy St J Whitley; Philip R Dash; Laura-Jo Ayling; Federico Prefumo; Baskaran Thilaganathan; Judith E Cartwright
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

2.  Increased resistance to apoptosis during differentiation and syncytialization of BeWo choriocarcinoma cells.

Authors:  Bih-Rong Wei; Chuan Xu; Neal S Rote
Journal:  Adv Biosci Biotechnol       Date:  2012-10-30

Review 3.  Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates.

Authors:  Ravid Shechter; Anat London; Michal Schwartz
Journal:  Nat Rev Immunol       Date:  2013-03       Impact factor: 53.106

4.  Association of the IL4R single-nucleotide polymorphism I50V with recurrent spontaneous abortion (RSA).

Authors:  Fataneh Tavasolian; Elham Abdollahi; Morteza Samadi
Journal:  J Assist Reprod Genet       Date:  2014-05-07       Impact factor: 3.412

5.  Expression of Keratin 8 and TNF-Related Apoptosis-I Inducing Ligand (TRAIL) in Down Syndrome Placentas.

Authors:  S D Klugman; S J Gross; J Liang; K Livne; B Gross; D Khabele; M Lopez-Jones; D R Cordero; S Reznik
Journal:  Placenta       Date:  2008-03-17       Impact factor: 3.481

Review 6.  T cell recognition and immunity in the fetus and mother.

Authors:  Cody A Koch; Jeffrey L Platt
Journal:  Cell Immunol       Date:  2007-10-24       Impact factor: 4.868

Review 7.  The Th1/Th2 paradigm: still important in pregnancy?

Authors:  Gérard Chaouat
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 11.759

Review 8.  Cell death mechanisms at the maternal-fetal interface: insights into the role of granulysin.

Authors:  Danijela Veljkovic Vujaklija; Sonja Sucic; Tamara Gulic; Marin Dominovic; Daniel Rukavina
Journal:  Clin Dev Immunol       Date:  2011-09-08

9.  BAX pro-apoptotic gene alterations in repeated pregnancy loss.

Authors:  Seyed Mohammad Seyedhassani; Massoud Houshmand; Seyed Mehdi Kalantar; Abbas Aflatoonian; Glayol Modabber; Feyzollah Hashemi-Gorji; Zahra Hadipour
Journal:  Arch Med Sci       Date:  2011-03-08       Impact factor: 3.318

10.  Dickkopf-3, a tissue-derived modulator of local T-cell responses.

Authors:  Michael Meister; Maria Papatriantafyllou; Viola Nordström; Varun Kumar; Julia Ludwig; Kathy O Lui; Ashleigh S Boyd; Zoran V Popovic; Thomas Henry Fleming; Gerhard Moldenhauer; Peter P Nawroth; Hermann-Josef Gröne; Herman Waldmann; Thilo Oelert; Bernd Arnold
Journal:  Front Immunol       Date:  2015-02-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.